Eliminating Bias in Patient Treatment and Opioid Prescribing

$109.00

To say that the opioid crisis and substance abuse problem is multifaceted is an understatement. One aspect of clinical care and treatment is bias, including during the prescribing of opioids and treatment associated with substance use disorder. This presentation provides an overview of opioids and substance abuse before diving into recent laws and developments associated with the SUPPORT Act, EKRA, as well as treatment during the COVID 19 pandemic. The participant should gain an understanding of key issues associated with this area of the law, as well as ways to maintain compliance in the dynamic regulatory landscape.

Want a discount? Become a member by purchasing LawPracticeCLE Unlimited or Limited Time Unlimited Special!

Event Details

Webinar Date

Webinar Time

Course Type

Course Instructor

Rachel V. Rose, JD, MBA

Original Date Of Course

General Credits

1

Course Description

To say that the opioid crisis and substance abuse problem is multifaceted is an understatement. One aspect of clinical care and treatment is bias, including during the prescribing of opioids and treatment associated with substance use disorder. This presentation provides an overview of opioids and substance abuse before diving into recent laws and developments associated with the SUPPORT Act, EKRA, as well as treatment during the COVID 19 pandemic. The participant should gain an understanding of key issues associated with this area of the law, as well as ways to maintain compliance in the dynamic regulatory landscape.

Principles

  • Overview of Opioids and Substance Abuse.
  • The SUPPORT Act and EKRA.
  • Eliminating Bias.
  • Ways to mitigate risk and improve compliance.

 

Syllabus

  1. Current Opioid Landscape
  2. What is bias and how can providers eliminate it?
  3. How the SUPPORT Act and EKRA impact substance use disorder treatment
  4. Recent Case Updates

Instructor

Rachel V. Rose, JD, MBA

You may also like…